1. Reich, DS, Lucchinetti, CF, Calabresi, PA. Multiple sclerosis. N Engl J Med 2018; 378(2): 169–180.
Google Scholar | Crossref | Medline2. Rocca, MA, Amato, MP, De Stefano, N, et al. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol 2015; 14(3): 302–317.
Google Scholar | Crossref | Medline | ISI3. Ruano, L, Portaccio, E, Goretti, B, et al. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler 2017; 23(9): 1258–1267.
Google Scholar | SAGE Journals | ISI4. Chiaravalloti, ND, DeLuca, J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7(12): 1139–1151.
Google Scholar | Crossref | Medline | ISI5. Amato, MP, Ponziani, G, Siracusa, G, et al. Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Arch Neurol 2001; 58(10): 1602–1606.
Google Scholar | Crossref | Medline6. Zipoli, V, Goretti, B, Hakiki, B, et al. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult Scler 2010; 16(1): 62–67.
Google Scholar | SAGE Journals | ISI7. Moccia, M, Lanzillo, R, Palladino, R, et al. Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression. Mult Scler 2016; 22(5): 659–667.
Google Scholar | SAGE Journals | ISI8. Deloire, M, Ruet, A, Hamel, D, et al. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later. Mult Scler 2010; 16(5): 581–587.
Google Scholar | SAGE Journals | ISI9. Wojcik, C, Fuchs, TA, Tran, H, et al. Staging and stratifying cognitive dysfunction in multiple sclerosis. Mult Scler. Epub ahead of print 6 May 2021. DOI: 10.1177/13524585211011390.
Google Scholar | SAGE Journals10. Salter, A, Tyry, T, Wang, G, et al. Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS. Neurol Clin Pract 2016; 6(5): 397–408.
Google Scholar | Crossref | Medline11. Middleton, LS, Denney, DR, Lynch, SG, et al. The relationship between perceived and objective cognitive functioning in multiple sclerosis. Arch Clin Neuropsychol 2006; 21(5): 487–494.
Google Scholar | Crossref | Medline12. Chruzander, C, Johansson, S, Gottberg, K, et al. A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: Changes in disability and the value of different factors in predicting disability and mortality. J Neurol Sci 2013; 332(1–2): 121–127.
Google Scholar | Crossref | Medline13. da Silva, AM, Torres, C, Ferreira, I, et al. Prognostic value of odor identification impairment in multiple sclerosis: 10-Years follow-up. Mult Scler Relat Disord 2020; 46: 102486.
Google Scholar | Crossref | Medline14. Martins Da Silva, A, Cavaco, S, Moreira, I, et al. Cognitive reserve in multiple sclerosis: Protective effects of education. Mult Scler 2015; 21(10): 1312–1321.
Google Scholar | SAGE Journals | ISI15. Polman, CH, Reingold, SC, Edan, G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.” Ann Neurol 2005; 58(6): 840–846.
Google Scholar | Crossref | Medline | ISI16. Manouchehrinia, A, Westerlind, H, Kingwell, E, et al. Age related Multiple Sclerosis Severity Score: Disability ranked by age. Mult Scler 2017; 23(14): 1938–1946.
Google Scholar | SAGE Journals | ISI17. Lublin, FD. New multiple sclerosis phenotypic classification. Eur Neurol 2014; 72(Suppl. 1): 1–5.
Google Scholar | Crossref | Medline | ISI18. University of California, San Francisco MS-EPIC Team , Cree, BA, Gourraud, PA, et al. Long-term evolution of multiple sclerosis disability in the treatment era. Ann Neurol 2016; 80(4): 499–510.
Google Scholar | Crossref | Medline19. Lassmann, H, van Horssen, J, Mahad, D. Progressive multiple sclerosis: Pathology and pathogenesis. Nat Rev Neurol 2012; 8(11): 647–656.
Google Scholar | Crossref | Medline | ISI20. Pitteri, M, Romualdi, C, Magliozzi, R, et al. Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study. Mult Scler 2017; 23(6): 848–854.
Google Scholar | SAGE Journals | ISI21. Schoonheim, MM, Hulst, HE, Brandt, RB, et al. Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology 2015; 84(8): 776–783.
Google Scholar | Crossref | Medline22. Eshaghi, A, Marinescu, RV, Young, AL, et al. Progression of regional grey matter atrophy in multiple sclerosis. Brain 2018; 141(6): 1665–1677.
Google Scholar | Crossref | Medline23. Sumowski, JF, Benedict, R, Enzinger, C, et al. Cognition in multiple sclerosis: State of the field and priorities for the future. Neurology 2018; 90(6): 278–288.
Google Scholar | Crossref | Medline24. Lunde, HMB, Assmus, J, Myhr, KM, et al. Survival and cause of death in multiple sclerosis: A 60-year longitudinal population study. J Neurol Neurosurg Psychiatry 2017; 88(8): 621–625.
Google Scholar | Crossref | Medline25. Scalfari, A, Knappertz, V, Cutter, G, et al. Mortality in patients with multiple sclerosis. Neurology 2013; 81(2): 184–192.
Google Scholar | Crossref | Medline26. Backstrom, D, Granåsen, G, Domellöf, ME, et al. Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study. Neurology 2018; 91(22): e2045–e2056.
Google Scholar | Crossref | Medline27. Smestad, C, Sandvik, L, Celius, EG. Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients. Mult Scler 2009; 15(11): 1263–1270.
Google Scholar | SAGE Journals | ISI28. Leray, E, Vukusic, S, Debouverie, M, et al. Excess mortality in patients with multiple sclerosis starts at 20 years from clinical onset: Data from a large-scale French observational study. PLoS ONE 2015; 10(7): e0132033.
Google Scholar | Crossref | Medline29. Kingwell, E, Zhu, F, Evans, C, et al. Causes that contribute to the excess mortality risk in multiple sclerosis: A population-based study. Neuroepidemiology 2020; 54(2): 131–139.
Google Scholar | Crossref | Medline30. Benedict, RHB, Amato, MP, DeLuca, J, et al. Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues. Lancet Neurol 2020; 19(10): 860–871.
Google Scholar | Crossref | Medline31. De Meo, E, Portaccio, E, Giorgio, A, et al. Identifying the distinct cognitive phenotypes in multiple sclerosis. JAMA Neurol 2021; 78(4): 414–425.
Google Scholar | Crossref | Medline32. Kalatha, T, Arnaoutoglou, M, Koukoulidis, T, et al. Does cognitive dysfunction correlate with neurofilament light polypeptide levels in the CSF of patients with multiple sclerosis? J Int Med Res 2019; 47(5): 2187–2198.
Google Scholar | SAGE Journals | ISI33. Gaetani, L, Salvadori, N, Lisetti, V, et al. Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis. J Neurol 2019; 266(9): 2157–2163.
Google Scholar | Crossref | Medline34. Magyari, M, Sorensen, PS. Comorbidity in multiple sclerosis. Front Neurol 2020; 11: 851.
Google Scholar | Crossref | Medline35. Rao, SM, Leo, GJ, Bernardin, L, et al. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41(5): 685–691.
Google Scholar | Crossref | Medline | ISI